SODIUM IODIDE I 123 Drug Patent Profile
✉ Email this page to a colleague
When do Sodium Iodide I 123 patents expire, and when can generic versions of Sodium Iodide I 123 launch?
Sodium Iodide I 123 is a drug marketed by Cardinal Health 418, Curium, and Ge Healthcare. and is included in four NDAs.
The generic ingredient in SODIUM IODIDE I 123 is sodium iodide i-123. There are one thousand four hundred and seventy-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium iodide i-123 profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SODIUM IODIDE I 123?
- What are the global sales for SODIUM IODIDE I 123?
- What is Average Wholesale Price for SODIUM IODIDE I 123?
Summary for SODIUM IODIDE I 123
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Clinical Trials: | 18 |
Patent Applications: | 10 |
What excipients (inactive ingredients) are in SODIUM IODIDE I 123? | SODIUM IODIDE I 123 excipients list |
DailyMed Link: | SODIUM IODIDE I 123 at DailyMed |
Recent Clinical Trials for SODIUM IODIDE I 123
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Stryker Endoscopy | Phase 4 |
University Health Network, Toronto | Phase 4 |
Osaka University | Phase 1 |
US Patents and Regulatory Information for SODIUM IODIDE I 123
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cardinal Health 418 | SODIUM IODIDE I 123 | sodium iodide i-123 | CAPSULE;ORAL | 018671-001 | May 27, 1982 | AA | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Ge Healthcare | SODIUM IODIDE I 123 | sodium iodide i-123 | CAPSULE;ORAL | 017630-003 | Jan 8, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Curium | SODIUM IODIDE I 123 | sodium iodide i-123 | CAPSULE;ORAL | 071909-001 | Feb 28, 1989 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Ge Healthcare | SODIUM IODIDE I 123 | sodium iodide i-123 | SOLUTION;ORAL | 017630-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |